In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the SCD ...

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion. As we reported ...

Sickle cell trait (SCT) is a genetic condition where individuals carry one copy of the sickle cell gene, making them carriers but generally symptom-free. This trait can be passed to offspring, ...

LMP Capital and Income Fund Inc (SCD) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium dividend score.

A new oral treatment, mitapivat, for sickle cell disease (SCD) significantly boosted hemoglobin levels in patients over a year, achieving one of the primary goals of a Phase 3 clinical trial. In the ...

Jairam Ramesh claimed that the country was not included in the initiative ‘given the sharp downturn in the Trump-Modi ties since May’.

Objective: Build an enterprise-grade Business Intelligence system that transforms transactional retail sales data into actionable insights for strategic decision-making.

Figure 1: Scd expression and identification of molecular lesions in ab mice. Figure 2: Expression of Scd in wild-type skin.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.